Your browser doesn't support javascript.
loading
Survival by Depth of Response and Efficacy by International Metastatic Renal Cell Carcinoma Database Consortium Subgroup with Lenvatinib Plus Pembrolizumab Versus Sunitinib in Advanced Renal Cell Carcinoma: Analysis of the Phase 3 Randomized CLEAR Study.
Grünwald, Viktor; Powles, Thomas; Kopyltsov, Evgeny; Kozlov, Vadim; Alonso-Gordoa, Teresa; Eto, Masatoshi; Hutson, Thomas; Motzer, Robert; Winquist, Eric; Maroto, Pablo; Keam, Bhumsuk; Procopio, Giuseppe; Wong, Shirley; Melichar, Bohuslav; Rolland, Frederic; Oya, Mototsugu; Rodriguez-Lopez, Karla; Saito, Kenichi; McKenzie, Jodi; Porta, Camillo.
Afiliação
  • Grünwald V; Interdisciplinary Genitourinary Oncology, Clinic for Urology, Clinic for Medical Oncology, University Hospital Essen, Essen, Germany. Electronic address: Viktor.Gruenwald@uk-essen.de.
  • Powles T; The Royal Free NHS Trust, London, England, UK.
  • Kopyltsov E; State Institution of Healthcare "Regional Clinical Oncology Dispensary", Omsk, Russia.
  • Kozlov V; State Budgetary Health Care Institution "Novosibirsk Regional Clinical Oncology Dispensary", Novosibirsk, Russia.
  • Alonso-Gordoa T; Hospital Universitario Ramón y Cajal, Madrid, Spain.
  • Eto M; Kyushu University, Fukuoka, Japan.
  • Hutson T; Texas Oncology, Dallas, TX, USA.
  • Motzer R; Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Winquist E; University of Western Ontario, London, Ontario, Canada.
  • Maroto P; Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
  • Keam B; Seoul National University Hospital, Seoul, Republic of Korea.
  • Procopio G; Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Italy.
  • Wong S; Western Health, VIC, Australia.
  • Melichar B; Palacký University Medical School and Teaching Hospital, Olomouc, Czech Republic.
  • Rolland F; Centre René Gauducheau Centre de Lutte Contre Le Cancer Nantes, Saint-Herblain, France.
  • Oya M; Keio University School of Medicine, Tokyo, Japan.
  • Rodriguez-Lopez K; Merck & Co., Inc, Rahway, NJ, USA.
  • Saito K; Eisai Inc, Nutley, NJ, USA.
  • McKenzie J; Eisai Inc, Nutley, NJ, USA.
  • Porta C; University of Bari 'A. Moro', Bari, Italy.
Eur Urol Oncol ; 6(4): 437-446, 2023 08.
Article em En | MEDLINE | ID: mdl-36720658
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Neoplasias Renais Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Humans Idioma: En Revista: Eur Urol Oncol Ano de publicação: 2023 Tipo de documento: Article País de publicação: Holanda
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Neoplasias Renais Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Humans Idioma: En Revista: Eur Urol Oncol Ano de publicação: 2023 Tipo de documento: Article País de publicação: Holanda